Reaching minority and underserved populations: the impact of the Cancer Information Service's outreach program. Part 3.
Through its regional outreach program, the Cancer Information Service (CIS) develops partnership with organizations that reach minority and underserved populations and connects them with accurate cancer information and an array of support services and resources. To evaluate the usefulness, satisfaction, and impact of the CIS outreach program on partner organizations, a national random sample survey was conducted by an independent research firm in 1996. This paper focuses on the survey results of 359 special population partner organizations that identified their main audience as a specific racial or ethnic group and/or the underserved. Almost all (84% to 93%) rated the services provided by the CIS outreach program to be very important or important to meeting the goals of their projects. A large majority of these special population partners stated that the CIS provided them with the latest cancer information (67%) and National Cancer Institute (NCI) resources (83%), and more than half (57%) utilized CIS expertise to develop and plan programs. Special populations partners were more likely to use an array of CIS assistance than other CIS partners. Furthermore, they were more likely to be heavy users of CIS assistance and more likely than other CIS partners to indicate that the CIS had an important impact on their programs. The results indicate that the CIS's nationally coordinated, regionally focused outreach program provides critical support and has an important impact on the cancer-related programs of partner organizations that reach minority and underserved audiences.
Kornfeld
J
J
Cancer Information Service, Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA.
Fleisher
L
L
Ter Maat
J
J
Vanchieri
C
C
Hohenemser
L
L
Stevens
N
N
D003159:Community-Institutional Relations; D003625:Data Collection; D006801:Humans; D007255:Information Services / Q000706:statistics & numerical data*; D008913:Minority Groups; D009316:National Institutes of Health (U.S.); D009369:Neoplasms; D015397:Program Evaluation; D014481:United States